The RFP Database
New business relationships start here

FDA Internal Control and Audit Management Software


Arkansas, United States
Government : Federal
RFP
Go to the link
This document has expired, therefore the above link may no longer work.

Notice Type: Combined Synopsis/Solicitation
Original Posted Date: June 21, 2017
Response Date: July 11, 2017
Original set aside: open market all businesses
Classification Code: 70 General Purpose Information Technology Equipment
NAICS 541519
Title: FDA Internal control and Audit Management Software

Synopsis: This is a combined synopsis solicitation for Internal Control Management Software in accordance with (FAR) 12.102(g) and in the format of Subpart 12.6 and 13.5 as supplemented with additional information included in this notice.


This announcement constitutes the only solicitation . Quotations are being requested. The solicitation number is FDA-SOL-17-1181159 and is issued as a Request for Proposals( RFP). This solicitation document incorporated all mandatory commercial items provision and clauses that are in effect through the Federal Acquisition circular 2005-95 dated 1/19/2017.


The North American Industrial classification Systems is 541519 and the small size standard is 35M 500L. This is a firm fixed price contract and is being issued as a "Brand Name or Equal to". If equal items are proposed, the quote shall provide product specification for those items proposed. All products proposed ( whether brand name listed or equal to items proposed) must satisfy the functional requirements/salient characteristics set forth in this document.


 


1.0 Background
The U.S. Food and Drug Administration (FDA) Office of Finance (OFM) is currently in the process of acquiring a COTS software to assist FDA in the management of its internal controls as required by the Federal Mangers Financial Integrity Act (FMFIA) and OMB Circular A-123. This software will allow more effective collaboration between OFM and all FDA Centers and Offices in the cataloging, and annual assessment of FDAs internal controls.
2.0 Objective
To obtain initial Control Management software and required associated license for software use; to support the FDA in the management of FDA's internal controls. The software is to allow for two user roles full (administrative) users, or equal, and casual (non-administrative/general) end users, or equal. Additionally, implementation/installation support services and training, Full (Administrative) user training, Casual (Non-Administrative/General end user training, and software maintenance to include telephone support and software updates must be provided.


3.0 Requirements
3.1 Software Requirements/Salient Characteristics


The salient functional characteristics of the Control Management software, shall consist of the following:


• Compatible with Windows 7 Operating System
• Web-based user interface
• Allow installation within the FDA environment to meet security requirements.
• Compatible with Windows Internet Explorer 11, Google Chrome, Mozilla Firefox internet browsers
• Compatible with FDA standard COTS office productivity software (Microsoft Word, Excel; Adobe Acrobat/PDFs)
• Provides ability for collaboration between various workgroups
o Allows for review and sign-off/certification of submitted information and documentation
o Maintains a record/audit log of changes and communications between users
• Provides the ability to develop and manage the annual assessment/audit programs.
• The software allows customization of input forms and fields as needed to support reporting requirements and established processes
• Provides ability to create and export reports and data.


3.2 Software Evaluation


The purchase of this software is contingent on the evaluation and acceptance by FDA's Office of Information Management and Technology (OIMT) and addition to the Master Approved Technologies (MAT) list. Prior to award, OIMT must evaluate the software and verify the software meets FDA standards for addition to the MAT list. If necessary , the vendor will provide the necessary materials, to include an evaluation copy and required technical documentation, as required to allow for OIMT's review. If the software is not accepted by OIMT and is not added to the MAT list, then the software cannot be accepted for this award.


3.2 Required Users/Licenses


The software is to allow access for 10 full (administrative) users, or equal, and 100 casual (non-administrative/general) end users, or equal. The vendor will provide the required licenses to allow access for these users.


4.0 Additional Requirements
Implementation, Training, and Support
• The vendor shall provide onsite training at the OFBA Offices located in Silver Spring, Maryland
• Training shall cover accessing and operating the software, including all major analytical functions and workflows, and include question and answer sessions
• The training shall be scheduled on a date mutually agreeable to the vendor and the DCCO point of contact
• Software Installation and Implementation
o Provide assistance in the software installation, and implementation of the software user interface to meet DCCO requirements for the collection, reporting, and management of information.
• Full (Administrative) User Training
o Provide training to Administrative Users to maintain and modify the user interface.
• Casual (Non-Administrative/General End Users) User Training
o Provide Non-Administrative End Users training on software functionality and use.
• Software Installation - Vendor (On-Site at OFBA Offices located in Silver Spring, Maryland or Remote)
o Assist DCCO Administrative Users with software installation on the FDA Network.
• Vendor Travel Costs for Software Implementation and Training (as required).
• Software Maintenance and Support
o For the duration of the contract, the vendor is to provide software maintenance, at a minimum to include telephone software support, and software updates and patches as required.
5. Deliverables


Item Quantity
Internal Control Software and Audit Management 1
Required Licenses, Quantity as required to allow access for specified User quantities As Required

Internal Control Software - Full User, or equal (Administrative Users) 10
Internal Control Software - Casual User, or equal (Non-Administrative/General End Users) 100
Software Installation and Implementation, To include vendor travel As Required
Full (Administrative) User Training; To include vendor travel As Required
Casual (Non-Administrative/General End Users) User Training; To include vendor travel As Required
Software Maintenance and Support, at a minimum to include telephone software support, and software updates and patches as required base year Per Year
Software Maintenance and Support, at a minimum to include telephone software support, and software updates and patches as required OY 1
Software Maintenance and Support, at a minimum to include telephone software support, and software updates and patches as required OY 2
Software Maintenance and Support, at a minimum to include telephone software support, and software updates and patches as required OY 3
Software Maintenance and Support, at a minimum to include telephone software support, and software updates and patches as required OY 4
6.0 Other Pertinent Information
The contractor shall deliver all software and licenses to the designated COR within 30 days of award.
6.1Place of performance:
Food & Drug Administration
8455 Colesville Road,
Silver Spring, MD
6.2 Contractor Officers Information
Karen Conroy: 781-587-7452
Email : karen.conroy@fda.hhs.gov
7.0 Period of Performance
The Base period of performance shall begin on the date of award and continue for 12 months.
In addition, there will be 4 option years for continued maintenance and software updates.
Base year plus 4 options years.
8.0 Security Compliance
1. Prior to the contractor removing any media from an FDA facility, the contractor shall ensure that all media has been wiped of FDA data to the approval of the FDA CISO.


2. Pursuant to Federal and HHS Information Security Program Policies, the contractor and any subcontractor performing under this task order shall comply with the following requirements:


a. Federal Information Security Management Act of 2002 (FISMA), Title III, E-Government Act of 2002, Pub. L. No. 107-347 (Dec. 17, 2002); http://csrc.nist.gov/policies/FISMA-final.pdf.


b. Information Type


i. Administrative, Management and Support Information:
• Information Management
• Lifecycle/Change Management
• Record Retention
• Budget and Finance
• Reporting and Information


ii. Mission Based Information
• Consumer Health and Safety


iii. Security Categories and Levels
• Confidentiality: Moderate
• Integrity: Moderate
• Availability Level: Low
• Overall: Moderate
3. Confidential Treatment of Sensitive Information


a. The Contractor shall guarantee strict confidentiality of the information/data that it is provided by the Government during the performance of the task order. The Government has determined that the information/data that the Contractor will be provided during the performance of the task order is of a sensitive nature.


b. Disclosure of the information/data, in whole or in part, by the Contractor can only be made after the Contractor receives prior written approval from the Contracting Officer. Whenever the Contractor is uncertain with regard to the proper handling of information/data under the contract, the Contractor shall obtain a written determination from the Contracting Officer.


9.0 INFORMATION TECHNOLOGY INVESTMENT MANAGEMENT/MASTER APPROVED TECHNOLOGIES LIST


The item acquired may require approval by the Food and Drug Administration (FDA) Office of Information Management (OIM) for operation in FDA's Information Technology environment (IT Investment Management Process/Master Approved Technologies List). Any item proposed not previously tested and approved for IT environment operations may require testing by OIM before award. Quoters must provide a full set of technical specifications with their offer. FDA will determine if further testing of the item is required. Consequently, the quoter shall be prepared to provide FDA with a demonstration unit within 2 days of offer submission.



10.0 Inspection and Acceptance Criteria
The Contracting Officer (CO) or duly authorized representative shall perform inspection and acceptance of products. The performance criteria for these products shall be timely delivery and closure of all activities and deliverables listed within Section 2 of this SOW and within the established Period of Performance.


11.0 Contract Order Type
The government anticipates awarding a firm-fixed price order.


12.0 508 Standard Requirements
Section 508 of the Rehabilitation Act of 1973 (29 U.S.C. 794d) standards apply to this order.
Section 508 Standards Requirement
Section 508 of the Rehabilitation Act of 1973 (29 U.S.C. 794d) requires Federal agencies to purchase electronic and information technologies (EIT) that meet specific accessibility standards. This law helps to ensure that federal employees with disabilities have access to, and use of, the information and data they need to do their jobs. Furthermore, this law ensures that members of the public with disabilities have the ability to access government information and services.
There are three regulations addressing the requirements detailed in Section 508. The Section 508 technical and functional standards are codified at 36 CFR Part 1194 and may be accessed through theAccess Board's Web site at http://www.access-board.gov. The second regulation issued to implement Section 508 is the Federal Acquisition Regulation (FAR). FAR Part 39.2 requires that agency acquisitions
of Electronic and Information Technology (EIT) comply with the Access Board's standards. The entire FAR is found at Chapter 1 of the Code of Federal Register (CFR) Title 48, located at http://www.acquisition.gov. The FAR rule implementing Section 508 can be found at http://www.section508.gov. The third applicable regulation is the HHS Acquisition Regulation (HHSAR). Regardless of format, all Web content or communications materials produced for publication on or
delivery via HHS Web sites - including text, audio or video - must conform to applicable Section 508 standards to allow federal employees and members of the public with disabilities to access information that is comparable to information provided to persons without disabilities. All contractors (including
subcontractors) or consultants responsible for preparing or posting content intended for use on an HHSfunded or HHS-managed Web site must comply with applicable Section 508 accessibility standards, and where applicable, those set forth in the referenced policy or standards documents below. Remediation of any materials that do not comply with the applicable provisions of 36 CFR Part 1194 as set forth in the SOW, shall be the responsibility of the contractor or consultant retained to produce the Web-suitable content or communications material.
Unless an agency exception to this requirement exists, the Contractor must conform to applicable Section 508 standards and must apply best practices associated with Section 508 compliance during the application design, development, and testing phases. The Contractor shall utilize FDA approved tools to verify the compliance with the Section 508 standards and ensure the delivery of the fully compliant
products.
The following Section 508 section applies:
1194.21 Software applications and operating systems
1194.31 Functional performance criteria
1194.41 Information, documentation, and support
13.0 Order of Precedence
The Contractor shall following the terms and conditions of this order. Should the Contractor include any additional terms and conditions resulting in conflicts between this document and the Contractor's document, the Order of Precedence shall be as specified in FAR Clause 52.212-4, dated May 2015. Any additional terms and conditions shall not be prohibited by applicable laws and regulations.


14.0 Provisions and Clauses Draft
The following clauses apply to this solicitation. When just the clause reference and title are listed, the clause is incorporated by reference. The full text of the FAR can be found here: http://farsite.hill.af.mil/


52.203-99, Prohibition on Contracting with Entities that Require Certain Internal Confidentiality Agreements (DEVIATION 2015-02)


(a) The Contractor shall not require employees or subcontractors seeking to report fraud, waste, or abuse to sign or comply with internal confidentiality agreements or statements prohibiting or otherwise restricting such employees or subcontractors from lawfully reporting such waste, fraud, or abuse to a designated investigative or law enforcement representative of a Federal department or agency authorized to receive such information.


(b) The contractor shall notify employees that the prohibitions and restrictions of any internal confidentiality agreements covered by this clause are no longer in effect.


(c) The prohibition in paragraph (a) of this clause does not contravene requirements applicable to Standard Form 312, Form 4414, or any other form issued by a Federal department or agency governing the nondisclosure of classified information.


(d)(1) In accordance with section 743 of Division E, Title VII, of the Consolidated and Further Continuing Resolution Appropriations Act, 2015 (Pub. L. 113-235), use of funds appropriated (or otherwise made available) under that or any other Act may be prohibited, if the Government determines that the Contractor is not in compliance with the provisions of this clause.

(2) The Government may seek any available remedies in the event the Contractor fails to comply with the provisions of this clause. (End of clause)


Health and Human Services Acquisition Regulation (HHSAR) Clauses can be viewed in full text at:


http://www.hhs.gov/policies/hhsar/subpart352.html#Subpart352.1--InstructionsforUsingProvisionsandClauses


Clause Clause Title Date
352.224-71 Confidential Information Dec 2015


Special Notice and Agreement regarding Software EULA/TOS


Computer software and services are often subject to license agreements, referred to as End User License Agreements (EULA), Terms of Service (TOS), or other similar legal instruments or agreements. Many of these agreements contain indemnification clauses that are inconsistent with Federal law and unenforceable, but which could create a violation of the Anti-Deficiency Act (31 U.S.C. 1341) if agreed to by the Government.


Therefore, by submitting a quotation the offeror shall agree that the inclusion of any Limitation of Liability, Indemnification, and any other clauses that conflict with Federal law or regulation in any EULA or TOS are NULL AND VOID. The offeror agrees that any EULA/TOS clauses conflicting with Federal law or regulation and are not agreed to by the Government if included with the submission of a quotation. Additionally, by submission of the quotation the offeror must agree to the inclusion of FAR 52.232-39 Unenforceability of Unauthorized Obligations in any resulting contract or order, if awarded.


52.252-2 Clauses Incorporated by Reference (Feb. 1998)
52.212-4 - Contract Terms and Conditions -- Commercial Items (May 2015)
52.212-5 - Contract Terms and Conditions Required to Implement Statutes or Executive Orders --
Commercial Items (May 2016)
52.217-8 - Option to Extend Services (Nov 1999)
52.217-9 Option to Extend the Term of the Contract (Mar 2000)
52.227-14 - Rights in Data - General. (May 2014)
52.227-19 - Commercial Computer Software License (Dec 2007)
52.232-39 - Unenforceability of Unauthorized Obligations (Jun 2013)
52.232-40 - Providing Accelerated Payment to Small Business Subcontractors (Dec 2013)
The below Health and Human Services Acquisition Regulation (HHSAR) Clauses apply. HHSAR
Clauses can be viewed in full text at: http://www.hhs.gov/grants/contracts/contract-policiesregulations/


15.0Certificate of Maintainability


At such time as the services of the Contractor are terminated, expire contractually or are otherwise not extended, or upon request by the Contracting Officer at any time, the Contractor shall issue, within five (5) working days, a "Certificate of Maintainability" for any or all equipment acquired and/or maintained under this contract.


The certificate shall state that preventive maintenance in accordance with the specifications of the Original Equipment Manufacturer (OEM) has been performed and that the equipment is performing in accordance with the OEM's specifications such that the OEM (or the OEM's successor in interest) would commit that it would assume maintenance of the equipment without billing any one-time charges (including but not limited to repair or inspection charges) if such maintenance were assumed effective the day after the Contractor's performance ceases. The Contractor is responsible for bearing all costs associated with obtaining such certification at no separate charge to the Government.


Should the Contractor fail to issue the required Certificate of Maintainability in accordance with this clause, or should any equipment fail to perform in accordance with the certification, the Contractor shall be liable to the Government for any reasonable costs incurred by the Government for the purpose of bringing the equipment up to the required OEM maintenance level.


If equipment is acquired under this contract, without maintenance of such equipment being concurrently acquired under the contract, the Contractor shall issue a Certificate of Maintainability for such equipment at the time of delivery for each piece of equipment. The certificate shall state that the equipment is in such condition that the OEM (or the OEM's successor in interest) would commit that it would assume maintenance of the equipment without billing any charges to the Government. All charges required obtaining the requisite performance of the equipment, up to the later of the time the equipment is accepted by the Government or the warranty expires, shall be borne by the Contractor. The time the equipment is accepted by the Government is the date that the Government determines that the equipment has passed acceptance testing, not the effective date of acceptance. The fact that the equipment may have been acquired with a warranty does not relieve the Contractor of its obligations under this clause.


16.0. FDA Three-Way Invoicing Instructions
16.1FDA Three-Way Invoicing Instructions
The contractor shall submit one (1) original copy of each invoice to the address specified below:


FDA/OC/OA/OFO/OFS
10903 New Hampshire Ave WO32 - Second Floor, MAIL HUB 2145
Silver Spring, MD 20993-0002 Attn: Vendor Payments
Phone 301-827-ERIC (3742)
fdavendorpaymentsteam@fda.gov


Invoices submitted under this contract must comply with the requirements set forth in FAR clauses 52.232-25 (Prompt Payment) and 52.232-33 (Payment By Electronic Funds Transfer - System for Award Management) and/or other applicable FAR clauses specified herein. To constitute a proper invoice, the invoice must be submitted on company letterhead and include each of the following:


(i) name and address of the contractor;
(ii) invoice date and invoice number;
(iii) purchase order/award number;
(iv) description, quantity, unit of measure, unit price, and extended price supplies delivered or services performed, including: (a) period of performance for which costs are claimed; (b) itemized travel costs, including origin and destination; and (c) any other supporting information necessary to clarify questionable expenditures;
(v) shipping number and date of shipment, including the bill of lading number and weight of shipment if shipped on government bill of lading;
(vi) terms of any discount for prompt payment offered;
(vii) name and address of official to whom payment is to be sent (must be the same as that in the purchase order/award, or in a proper notice of assignment)
(viii) name, title, and phone number of person to notify in event of defective invoice;
(ix) taxpayer identification number (tin);
(x) electronic funds transfer (EFT) banking information, including routing transit number of the financial institution receiving payment;
(xi) name and telephone number of the FDA Contracting Officer's Representative (COR) or other program center/office point of contact, as referenced on the purchase order;


(xii) any other information or documentation required by the purchase order/award; and


(xiii) Contract Line Item Number (CLIN) that is being invoiced against. An electronic invoice is acceptable. Questions regarding invoice payments should be directed to the FDA Payment Office at a telephone number provided above.



17.0 Authorized Contractor
The Contractor shall be the software Original Equipment Manufacturer (OEM) or an authorized reseller/servicing agent of the software OEM.
The Quoter shall notify the Contract Specialist / Contracting Officer immediately if this requirement is registered by a reseller with the Original Equipment Manufacturer (OEM).


18.0 Instruction to Quoters:
Instructions to Quoters:
Quoters shall submit an electronic copy to Karen Conroy via email @ karen.conroy@fda.hhs.gov no later than July 11, 2017 @ 2;00pm Eastern Time.Questions are no later than June 29, 2017 2;00pm eastern standard times.
Quoters shall submit a technical volume and a pricing volume.
Volume One -Technical
• Demonstrates the Quoter's capability to meet each requirement as described under requirements, additional requirements, and deliverables
• VPAT information shall be submitted
• Volume one shall not exceed five pages The five pages does not include brochures or additional information that will assist in providing detailed information about what is being offered
Quoters responding to this RFQ must be registered by a reseller with the Original Equipment Manufacturer (OEM).in the Systems for Award Management (SAM): http:www.sam.gov


Volume Two- Pricing
Total pricing for each product listed under #5 Deliverables
19. Evaluation Method:


Quotes will be evaluated on a lowest price technically acceptable basis. Technical acceptability will be determined by a quoter's ability to meet each of the requirements listed under requirements, additional requirements, and deliverable. Among those quotes determined to be technically acceptable, the Government will award to the lowest priced quote.


 


Karen L Conroy, Phone 7815877452, Fax 781-596-7896, Email karen.conroy@fda.hhs.gov

    1. Home
    2. Articles
    3. Login or Register

    4. Search

    5. Add/Announce your RFP